Talis Biomedical Corporation Announces Resignation of Melissa Gilliam from its Board of Directors, as Member of Nominating and Corporate Governance Committee and as Member and Co-Chairperson of Science, Technology and Clinical Affairs Committee

Talis Biomedical Corporation announced on August 30, 2023, Dr. Melissa Gilliam notified the Company of her resignation from the Company?s Board of Directors, as a member of the Nominating and Corporate Governance Committee and as a member and co-chairperson of the Science, Technology and Clinical Affairs Committee, effective as of August 31, 2023. Dr. Gilliam?s resignation was not due to any disagreement with the Company on any matter related to the Company?s operations, policies or practices.